Therefore, further in-depth studies at the cellular level are warranted to determine the exact mechanism by which Tfr deficiency affects DCM pathogenesis, and to assess whether such cells could be used as potential therapeutic targets in DCM. Here, TFRC is linked to familial dilated cardiomyopathy.